<table border="1"><tr><th>System (IUPAC) name</th><td><ul><li>3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one</li></ul></td></tr><tr><th>Product name</th><td><ul><li>Risperdal and Others</li></ul></td></tr><tr><th>Drugs.com</th><td><ul><li>Monograph</li></ul></td></tr><tr><th>MedlinePlus</th><td><ul><li>a694015</li></ul></td></tr><tr><th>Pregnancy classification</th><td><ul><li>AU | B3 | US | C (not excluding the possibility of risk)</li></ul></td></tr><tr><th>Methods of administration</th><td><ul><li>Injection of muscles through oral ( tablets or liquids)</li></ul></td></tr><tr><th>Legal status</th><td><ul><li>AU | Limit doctor prescription (S4) | UK | Prescription (|  | -only) (POM) | US | Prescription (|  | -only)</li></ul></td></tr><tr><th>Bioavailability</th><td><ul><li>70% (oral)</li></ul></td></tr><tr><th>Metabolism</th><td><ul><li>Liver (CYP2D6 mediated to 9-hydroxyrisperidone)</li></ul></td></tr><tr><th>Biological half-life</th><td><ul><li>20 hours (oral), 3â€“6 days (muscle injection)</li></ul></td></tr><tr><th>Excretion</th><td><ul><li>Urine (70%), feces (14%)</li></ul></td></tr><tr><th>CAS Registration No.</th><td><ul><li>106266-06-2</li></ul></td></tr><tr><th>ATC Code</th><td><ul><li>N05 | AX08</li></ul></td></tr><tr><th>PubChem</th><td><ul><li>CID | 5073</li></ul></td></tr><tr><th>IUPHAR/BPS | ( | English | IUPHAR/BPS | )</th><td><ul><li>96</li></ul></td></tr><tr><th>DrugBank</th><td><ul><li>DB00734</li></ul></td></tr><tr><th>ChemSpider</th><td><ul><li>4895</li></ul></td></tr><tr><th>UNII</th><td><ul><li>L6UH7ZF8HC</li></ul></td></tr><tr><th>KEGG</th><td><ul><li>D00426</li></ul></td></tr><tr><th>ChEBI</th><td><ul><li>CHEBI:8871</li></ul></td></tr><tr><th>ChEMBL | ( | English | ChEMBL | )</th><td><ul><li>CHEMBL85</li></ul></td></tr><tr><th>Chemicals</th><td><ul><li>C | 23 | H | 27 | F | N | 4 | O | 2</li></ul></td></tr><tr><th>Mold Quality</th><td><ul><li>410.485 g/mol</li></ul></td></tr></table>